Tayler A. Buchan

Tayler A. Buchan

Auto-generated profile, based on publicly available information

Tayler A. Buchan

Ted Rogers Center for Heart Research, Peter Munk Cardiac Center, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
KLKimberley Lau
Kimberley Lau
AMAbdullah Malik
Abdullah Malik
FFFarid Foroutan
Farid Foroutan
TBTayler A. Buchan
Tayler A. Buchan
JDJulian F. Daza
Julian F. Daza
AAAna C. Alba
Ana C. Alba

8 April 2021 in Heart
Verified
Journal Article
Closed access
PDF file
TBTayler A Buchan
Tayler A Buchan
AMAbdullah Malik
Abdullah Malik
CCCynthia Chan
Cynthia Chan
JCJason Chambers
Jason Chambers
YSYujin Suk
Yujin Suk
FFFarid Foroutan
Farid Foroutan
Objective To inform a clinical practice guideline (BMJ Rapid Recommendations) considering sodium glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists for treatment of adults with type 2 diabetes, we summarised the available evidence regarding the performance of validated risk models on cardiovascular and kidney outcomes in these patients. Methods We systematically searched bibliographic databases in January 2020 to identify observational studies evaluating risk models for all-cause and cardiovascular mortality, heart failure (HF) hospitalisations, end-stage kidney disease (ESKD), myocardial infarction (MI) and ischaemic stroke in ambulatory adults with type 2 diabetes. Using a random effects model, we pooled discrimination measures for each model and outcome, separately, and descriptively summarised calibration plots, when available. We used the Prediction Model Risk of Bias Assessment Tool to assess risk of bias of each included study and the Grading of Recommendations, Assessment, Development, and Evaluation approach to evaluate our certainty in the evidence. Results Of 22 589 publications identified, 15 observational studies reporting on seven risk models proved eligible. Among the seven models with >1 validation cohort, the Risk Equations for Complications of Type 2 Diabetes (RECODe) had the best calibration in primary studies and the highest pooled discrimination measures for the following outcomes: all-cause mortality (C-statistics 0.75, 95% CI 0.70 to 0.80; high certainty), cardiovascular mortality (0.79, 95% CI 0.75 to 0.84; low certainty), ESKD (0.73, 95% CI 0.52 to 0.94; low certainty), MI (0.72, 95% CI 0.69 to 0.74; moderate certainty) and stroke (0.71, 95% CI 0.68 to 0.74; moderate certainty). This model does not, however, predict risk of HF hospitalisations. Conclusion Of available risk models, RECODe proved to have satisfactory calibration in primary validation studies and acceptable discrimination superior to other models, though with high risk of bias in most primary studies. Trial registration number CRD42020168351.

14 November 2020 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
TBTayler A. Buchan
Tayler A. Buchan
Behnam SadeghiradBehnam Sadeghirad
Behnam Sadeghirad
NSNayeli Schmutz
Nayeli Schmutz
NGNicolai Goettel
Nicolai Goettel
FFFarid Foroutan
Farid Foroutan
BDBenjamin T. Dodsworth
Benjamin T. Dodsworth
Background: Early identification of patients at risk for postoperative delirium is essential because adequate well-timed interventions could reduce the occurrence of delirium and the related detrimental outcomes. Methods: We will conduct a systematic review and individual patient data (IPD) meta-analysis of prognostic studies evaluating the predictive value of risk factors associated with an increased risk of postoperative delirium in elderly patients undergoing elective surgery. We will identify eligible studies through systematic search of MEDLINE, EMBASE, and CINAHL from their inception to May 2020. Eligible studies will enroll older adults (≥ 50 years) undergoing elective surgery and assess pre-operative prognostic risk factors for delirium and incidence of delirium measured by a trained individual using a validated delirium assessment tool. Pairs of reviewers will, independently and in duplicate, screen titles and abstracts of identified citations, review the full texts of potentially eligible studies. We will contact chief investigators of eligible studies requesting to share the IPD to a secured repository. We will use one-stage approach for IPD meta-analysis and will assess certainty of evidence using the GRADE approach. Discussion: Since we are using existing anonymized data, ethical approval is not required for this study. Our results can be used to guide clinical decisions about the most efficient way to prevent postoperative delirium in elderly patients. Systematic review registration: CRD42020171366.

1 January 2020 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
TBTayler A. Buchan
Tayler A. Buchan
HRHeather J. Ross
Heather J. Ross
MMMichael McDonald
Michael McDonald
PBPhyllis Billia
Phyllis Billia
DDDiego Delgado
Diego Delgado
AAAna C. Alba
Ana C. Alba

1 July 2023 in Circulation: Heart Failure
Verified
Journal Article
Closed access
AAAna C. Alba
Ana C. Alba
TBTayler A. Buchan
Tayler A. Buchan
SSSudipta Saha
Sudipta Saha
SFSteve Fan
Steve Fan
CDCatherine Demers
Catherine Demers
GGGordon H. Guyatt
Gordon H. Guyatt
BACKGROUND: Many studies have demonstrated that physicians often err in estimating patient prognosis. No studies have directly compared physician to model predictive performance in heart failure (HF). We aimed to compare the accuracy of physician versus model predictions of 1-year mortality. METHODS: This multicenter prospective cohort study on 11 HF clinics in 5 provinces in Canada included consecutive consented outpatients with HF with reduced left ventricular ejection fraction (10% in both low- and high-risk patients (poor calibration). In risk reclassification analysis, among patients without events, the SHFM better classified 51% in comparison to HF cardiologists and 43% in comparison to family doctors. In patients with events, the SHFM erroneously assigned lower risk to 44% in comparison to HF cardiologists and 34% in comparison to family doctors. CONCLUSIONS: Family doctors and HF cardiologists showed adequate risk discrimination, with however substantial overestimation of absolute risk. Predictive models showed higher accuracy. Incorporating models in family and HF cardiology practices may improve patient care and resource use in HF with reduced left ventricular ejection fraction. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04009798.

16 October 2023 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
AAAna C. Alba
Ana C. Alba
ADAndrea J. Darzi
Andrea J. Darzi
TBTayler A. Buchan
Tayler A. Buchan
EKElena Kum
Elena Kum
KUKathryn Uhlman
Kathryn Uhlman
GGGordon Guyatt
Gordon Guyatt